Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation

Mesenchymal stem cells (MSCs), due to their potential for differentiation into alveolar epithelial cells and their immunosuppressive characteristics, are considered a new therapeutic agent in cell-based therapy of inflammatory lung disorders, including chronic obstructive pulmonary disease (COPD). S...

Full description

Bibliographic Details
Published in:Analytical Cellular Pathology
Main Authors: Carl Randall Harrell, Dragica Miloradovic, Ruxana Sadikot, Crissy Fellabaum, Bojana Simovic Markovic, Dragana Miloradovic, Aleksandar Acovic, Valentin Djonov, Nebojsa Arsenijevic, Vladislav Volarevic
Format: Article
Language:English
Published: Wiley 2020-01-01
Online Access:http://dx.doi.org/10.1155/2020/3153891